top of page
Lecture 12: Thrombosis in Cancer
Gerald A Soff, MD
Presentation Date:
December 11, 2025
> Venous thromboembolism (VTE), is major source of morbidity and mortality in cancer patients.
> Incidence rates of cancer-associated thrombosis (CAT) vary with cancer type, stage, treatment, and comorbidities, but it is estimated that approximately 15-20 % of cancer patients will develop a venous thromboembolic episode at some point during the course of their illness.
Gerald A Soff MD
Chief, Classical Hematology Service
Sylvester Comprehensive Cancer Center,
University of Miami Health System
gas199@Miami.edu
Disclosures for Gerald A Soff MD.
Research Support (Past 2 years):
Amgen, Sobi/Dova Pharmaceuticals
Anthos Therapeutics
Data Safety Monitoring Committee
Alpine Immune Sciences
Advisory Boards (Past 2 years)
Sanofi , Novartis
Learning Objectives: Thrombosis in Cancer
>The Scope of The Problem
>Pathophysiology
> Management
Left: Armand Trousseau
(14 October 1801 – 23 June 1867)
Widely creditted as the first to describe the association of cancer and a hypercoagulable state.
Starting in 2025, lectures are eligible for Continuing Education Credit.
Link for CE:
bottom of page